AURA
AURA
US05153U1079
Aura Biosciences, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
112.791.000 96.116.000
17.3%
Operating Income -112.791.000 -96.116.000
17.3%
Pretax Income -106.083.000 -86.807.000
22.2%
Net Income Common Stockholders -106.191.000 -86.919.000
22.2%
-- --
--
-- --
--
ende